(Q72216471)

English

Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects

scientific article published on 01 April 1993

Statements

Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit